rosiglitazone has been researched along with Autoimmune Diabetes in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (52.00) | 29.6817 |
| 2010's | 12 (48.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, HE; Breyer, MD; Cramer, MS; Harlan, SM; Heinz-Taheny, KM; Heuer, JG; Jaqua, DL; Qi, Z; Shiyanova, TL; Sullivan, JM; Wei, T | 1 |
| Chen, LJ; Cheng, JT; Cherng, YG; Hsu, CT; Huang, KC | 1 |
| Chen, LJ; Cheng, MF; Ku, PM; Lin, JW | 1 |
| Ennis, WJ; Fang, MM; Koh, TJ; Mirza, RE; Novak, ML; Sui, A; Urao, N | 1 |
| Cander, S; Ersoy, C; Guclu, M; Oz Gul, O; Ozkaya, G; Sarandol, E; Unal, O | 1 |
| Guo, F; Liu, L; Song, W; Wang, Q; Xiong, L; Yang, R; Zhong, H | 1 |
| Aiello, LP; Child, A; Folkman, J; Shen, LQ; Weber, GM | 1 |
| Huang, G; Li, X; Lin, J; Yang, Z; Zhou, Z | 1 |
| Guo, HF; Li, D; Li, ZR; Liu, ZY; Shao, H; Si, SY; Yang, Y; Yang, Z | 1 |
| Chu, SH; Chun, SH; Li, AH | 1 |
| Choi, JE; Choi, JM; Kim, DH; Kim, SW; Lee, WJ; Park, JS; Yoon, SY | 1 |
| Bravard, A; Disse, E; Laville, M; Lefai, E; Meugnier, E; Peretti, N; Pesenti, S; Rabasa-Lhoret, R; Rieusset, J; Vidal, H; Vouillarmet, J | 1 |
| Ayanoğlu-Dülger, G; Çelikel, Ç; Elçioğlu, HK; Kabasakal, L; Özkan, N | 1 |
| Atkinson, M; Cooper-DeHoff, RM; Davoodi-Semiromi, A; Hassanzadeh, A; Wabitsch, M; Wasserfall, CH | 1 |
| Graham, M; Lindsey, C; McMurphy, J | 1 |
| Atar, M; Atar-Zwillenberg, DR; Spornitz, UM; Verry, P | 1 |
| Füchtenbusch, M; Löbner, K | 1 |
| Raskin, P; Strowig, SM | 1 |
| Allen, TJ; Calkin, AC; Cooper, ME; Forbes, JM; Jandeleit-Dahm, KA; Lassila, M; Smith, CM | 1 |
| Orchard, TJ | 1 |
| Taéron, C | 1 |
| Cefalu, WT; Wang, ZQ | 1 |
| Brophy, S; Brunt, H; Davies, H; Mannan, S; Williams, R | 1 |
| Chillarón, JJ; Goday, A; Pedro-Botet, J | 1 |
| Anderson, D; Chisholm, D; Craig, ME; Crock, P; Donaghue, KC; Stone, ML; Verge, CF; Walker, JL | 1 |
3 review(s) available for rosiglitazone and Autoimmune Diabetes
| Article | Year |
|---|---|
[Inflammation and diabetes].
Topics: Adiponectin; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Blood Glucose; Body Weight; C-Reactive Protein; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Exercise; Humans; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Metabolic Syndrome; Obesity; Research; Risk Factors; Rosiglitazone; Thiazolidinediones | 2004 |
Interventions for latent autoimmune diabetes (LADA) in adults.
Topics: Adult; Autoimmune Diseases; C-Peptide; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Glutamate Decarboxylase; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Randomized Controlled Trials as Topic; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones | 2007 |
[Metabolic syndrome, type 1 diabetes mellitus and insulin resistance].
Topics: Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metabolic Syndrome; Rosiglitazone; Thiazolidinediones | 2008 |
4 trial(s) available for rosiglitazone and Autoimmune Diabetes
| Article | Year |
|---|---|
Effect of Rosiglitazone and Insulin Combination Therapy on Inflammation Parameters and Adipocytokine Levels in Patients with Type 1 DM.
Topics: Adipokines; Adiponectin; Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fibrinogen; Humans; Hyperglycemia; Hypoglycemic Agents; Inflammation; Insulin; Insulin Secretion; Leptin; Male; Middle Aged; Prognosis; Prospective Studies; Resistin; Rosiglitazone; Thiazolidinediones; Young Adult | 2015 |
Rosiglitazone preserves islet beta-cell function of adult-onset latent autoimmune diabetes in 3 years follow-up study.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Middle Aged; Rosiglitazone; Sulfonylurea Compounds; Thiazolidinediones | 2009 |
The effect of rosiglitazone on overweight subjects with type 1 diabetes.
Topics: Adult; Blood Glucose; Body Mass Index; Body Size; C-Peptide; Diabetes Mellitus, Type 1; Double-Blind Method; Ethnicity; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Obesity; Placebos; Rosiglitazone; Thiazolidinediones; Weight Gain | 2005 |
The addition of rosiglitazone to insulin in adolescents with type 1 diabetes and poor glycaemic control: a randomized-controlled trial.
Topics: Adiponectin; Adolescent; Blood Glucose; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2008 |
18 other study(ies) available for rosiglitazone and Autoimmune Diabetes
| Article | Year |
|---|---|
Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
Topics: Animals; Antihypertensive Agents; Creatinine; Dependovirus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Disease Progression; Female; Genetic Vectors; Hypertension; Hypoglycemic Agents; Janus Kinases; Lac Operon; Lisinopril; Male; Mice; Nephrectomy; Nitric Oxide Synthase Type III; Renin; Rosiglitazone; Serum Albumin; Severity of Illness Index; Signal Transduction; STAT Transcription Factors | 2018 |
Rosiglitazone is effective to improve renal damage in type-1-like diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glucuronidase; Kidney; Klotho Proteins; Male; PPAR gamma; Rats, Wistar; Receptor, Fibroblast Growth Factor, Type 1; Rosiglitazone; Thiazolidinediones | 2014 |
Rosiglitazone increases cerebral klotho expression to reverse baroreflex in type 1-like diabetic rats.
Topics: Administration, Oral; Animals; Baroreflex; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucuronidase; Heart Rate; Humans; Injections, Intraventricular; Klotho Proteins; Male; Medulla Oblongata; Rats, Wistar; Recombinant Proteins; Rosiglitazone; Streptozocin; Thiazolidinediones | 2014 |
Macrophage PPARγ and impaired wound healing in type 2 diabetes.
Topics: Administration, Cutaneous; Animals; Cells, Cultured; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Humans; Interleukin-1beta; Leg Ulcer; Macrophages; Male; Mice, Inbred C57BL; Mice, Knockout; Phenotype; PPAR gamma; Prostaglandin D2; Receptors, Interleukin-1 Type I; Rosiglitazone; Skin; Thiazolidinediones; Time Factors; Wound Healing | 2015 |
Therapeutic window of globular adiponectin against cerebral ischemia in diabetic mice: the role of dynamic alteration of adiponectin/adiponectin receptor expression.
Topics: Adiponectin; Animals; Apoptosis; Brain Ischemia; Caspase 12; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; eIF-2 Kinase; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation; Heat-Shock Proteins; Humans; Hypoglycemic Agents; Injections, Intraventricular; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Neurons; Neuroprotective Agents; Protein Serine-Threonine Kinases; Receptors, Adiponectin; Reperfusion Injury; RNA, Small Interfering; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factor CHOP | 2015 |
Rosiglitazone and delayed onset of proliferative diabetic retinopathy.
Topics: Aged; Angiogenesis Inhibitors; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Female; Humans; Hypoglycemic Agents; Longitudinal Studies; Macular Edema; Male; Medical Records; Middle Aged; PPAR gamma; Retrospective Studies; Risk Reduction Behavior; Rosiglitazone; Thiazolidinediones; Visual Acuity | 2008 |
The effect of substituted thiophene and benzothiophene derivates on PPARgamma expression and glucose metabolism.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Type 1; Female; Glucose Tolerance Test; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Mice; Mice, Inbred NOD; PPAR gamma; Rosiglitazone; Thiazolidinediones; Thiophenes; Transcriptional Activation | 2010 |
Association of proliferative diabetic retinopathy with insulin use and microalbuminuria.
Topics: Albuminuria; Angiogenesis Inhibitors; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Progression; Humans; Hypoglycemic Agents; Insulin; Macular Edema; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2010 |
Rosiglitazone reduces tau phosphorylation via JNK inhibition in the hippocampus of rats with type 2 diabetes and tau transfected SH-SY5Y cells.
Topics: Animals; Blotting, Western; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Humans; Hypoglycemic Agents; Infant; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Inbred C57BL; Neurons; Phosphorylation; Polymerase Chain Reaction; PPAR gamma; Rats; Rats, Inbred OLETF; Rosiglitazone; tau Proteins; Thiazolidinediones; Transfection; Treatment Outcome | 2010 |
FTO is increased in muscle during type 2 diabetes, and its overexpression in myotubes alters insulin signaling, enhances lipogenesis and ROS production, and induces mitochondrial dysfunction.
Topics: Adenosine Triphosphate; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Biopsy; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Genetic Vectors; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Mitochondria, Muscle; Muscle Fibers, Skeletal; Muscle, Skeletal; Oligonucleotide Array Sequence Analysis; Oxidative Stress; Proteins; Reactive Oxygen Species; RNA; Rosiglitazone; Signal Transduction; Thiazolidinediones | 2011 |
A study comparing the effects of rosiglitazone and/or insulin treatments on streptozotocin induced diabetic (type I diabetes) rat aorta and cavernous tissues.
Topics: Animals; Aorta; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glutathione; Inflammation; Insulin; Lipid Peroxidation; Male; Muscle Relaxation; Penis; Rats; Rosiglitazone; Thiazolidinediones | 2011 |
Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes.
Topics: Adipocytes; Adiponectin; Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 1; DNA-Binding Proteins; Enzyme Inhibitors; Glucose; Hypoglycemic Agents; Janus Kinases; Mice; Mice, Inbred NOD; PPAR gamma; Protein-Tyrosine Kinases; Rosiglitazone; Thiazolidinediones; Tyrphostins | 2013 |
A retrospective review of thiazolidinediones with development of a troglitazone conversion protocol.
Topics: Aged; Alanine Transaminase; Chromans; Clinical Protocols; Contraindications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Monitoring; Drug Utilization Review; Guideline Adherence; Humans; Hypoglycemic Agents; Male; Middle Aged; Practice Guidelines as Topic; Quality Assurance, Health Care; Retrospective Studies; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Troglitazone; United States; United States Department of Veterans Affairs | 2003 |
Defective enamel ultrastructure in diabetic rodents.
Topics: Animals; Calcium; Dental Enamel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Hypoglycemic Agents; Mice; Microscopy, Electron, Scanning; Phosphorus; Rats; Rats, Zucker; Rosiglitazone; Thiazolidinediones | 2004 |
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effects.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Oxidative Stress; Rosiglitazone; Thiazolidinediones; Triglycerides; Vasculitis | 2005 |
The effect of rosiglitazone on overweight subjects with type 1 diabetes.
Topics: Blood Pressure; Diabetes Mellitus, Type 1; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Obesity; Rosiglitazone; Thiazolidinediones; Waist-Hip Ratio | 2006 |
[Rosiglitazone].
Topics: Diabetes Mellitus, Type 1; Drug Monitoring; Humans; Hypoglycemic Agents; Nurse's Role; Patient Education as Topic; Rosiglitazone; Thiazolidinediones; Weight Gain | 2006 |
Clinical research observations with use of exubera in patients with type 1 and 2 diabetes.
Topics: Administration, Inhalation; Administration, Oral; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Equipment Design; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Antibodies; Nebulizers and Vaporizers; Rosiglitazone; Thiazolidinediones | 2007 |